Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

Rebecca S. Muraoka, Yasuhiro Koh, L. Renee Roebuck, Melinda E. Sanders, Dana Brantley-Sieders, Agnieszka E. Gorska, Harold L. Moses, Carlos L. Arteaga

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

To determine if Neu is dominant over transforming growth factor β (TGF-β), we crossed mouse mammary tumor virus (MMTV)-Neu mice with MMTV-TGF-β1S223/225 mice expressing active TGF-β1 in the mammary gland. Bigenic (NT) and Neu-induced mammary tumors developed with a similar latency. The bigenic tumors and their metastases were less proliferative than those occurring in MMTV-Neu mice. However, NT tumors exhibited less apoptosis and were more locally invasive and of higher histological grade. NT mice exhibited more circulating tumor cells and lung metastases than Neu mice, while NT tumors contained higher levels of phosphorylated (active) Smad2, Akt, mitogen-activated protein kinase (MAPK), and p38, as well as vimentin content and Rac1 activity in situ than tumors expressing Neu alone. Ex vivo, NT cells exhibited higher levels of P-Akt and P-MAPK than Neu cells. These were inhibited by the TGF-β inhibitor-soluble TGF-β type II receptor (TβRII:Fc), suggesting they were activated by autocrine TGF-β. TGF-β stimulated migration of Neu cells into surrounding matrix, while the soluble TGF-β inhibitor abrogated motility and invasiveness of NT cells. These data suggest that (i) the antimitogenic and prometastatic effects of TGF-β can exist simultaneously and (ii) Neu does not abrogate TGF-β-mediated antiproliferative action but can synergize with TGF-β in accelerating metastatic tumor progression.

Original languageEnglish (US)
Pages (from-to)8691-8703
Number of pages13
JournalMolecular and Cellular Biology
Volume23
Issue number23
DOIs
StatePublished - Dec 1 2003

Fingerprint

Transforming Growth Factors
Breast Neoplasms
Neoplasms
Mouse mammary tumor virus
Growth Inhibitors
Neoplasm Metastasis
Circulating Neoplastic Cells
Growth Factor Receptors
p38 Mitogen-Activated Protein Kinases
Vimentin
Human Mammary Glands
Mitogen-Activated Protein Kinases
Cell Movement
Apoptosis
Lung

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1. / Muraoka, Rebecca S.; Koh, Yasuhiro; Roebuck, L. Renee; Sanders, Melinda E.; Brantley-Sieders, Dana; Gorska, Agnieszka E.; Moses, Harold L.; Arteaga, Carlos L.

In: Molecular and Cellular Biology, Vol. 23, No. 23, 01.12.2003, p. 8691-8703.

Research output: Contribution to journalArticle

Muraoka, RS, Koh, Y, Roebuck, LR, Sanders, ME, Brantley-Sieders, D, Gorska, AE, Moses, HL & Arteaga, CL 2003, 'Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1', Molecular and Cellular Biology, vol. 23, no. 23, pp. 8691-8703. https://doi.org/10.1128/MCB.23.23.8691-8703.2003
Muraoka, Rebecca S. ; Koh, Yasuhiro ; Roebuck, L. Renee ; Sanders, Melinda E. ; Brantley-Sieders, Dana ; Gorska, Agnieszka E. ; Moses, Harold L. ; Arteaga, Carlos L. / Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1. In: Molecular and Cellular Biology. 2003 ; Vol. 23, No. 23. pp. 8691-8703.
@article{f93c9c3fcd514a839a3f477b9775ee69,
title = "Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1",
abstract = "To determine if Neu is dominant over transforming growth factor β (TGF-β), we crossed mouse mammary tumor virus (MMTV)-Neu mice with MMTV-TGF-β1S223/225 mice expressing active TGF-β1 in the mammary gland. Bigenic (NT) and Neu-induced mammary tumors developed with a similar latency. The bigenic tumors and their metastases were less proliferative than those occurring in MMTV-Neu mice. However, NT tumors exhibited less apoptosis and were more locally invasive and of higher histological grade. NT mice exhibited more circulating tumor cells and lung metastases than Neu mice, while NT tumors contained higher levels of phosphorylated (active) Smad2, Akt, mitogen-activated protein kinase (MAPK), and p38, as well as vimentin content and Rac1 activity in situ than tumors expressing Neu alone. Ex vivo, NT cells exhibited higher levels of P-Akt and P-MAPK than Neu cells. These were inhibited by the TGF-β inhibitor-soluble TGF-β type II receptor (TβRII:Fc), suggesting they were activated by autocrine TGF-β. TGF-β stimulated migration of Neu cells into surrounding matrix, while the soluble TGF-β inhibitor abrogated motility and invasiveness of NT cells. These data suggest that (i) the antimitogenic and prometastatic effects of TGF-β can exist simultaneously and (ii) Neu does not abrogate TGF-β-mediated antiproliferative action but can synergize with TGF-β in accelerating metastatic tumor progression.",
author = "Muraoka, {Rebecca S.} and Yasuhiro Koh and Roebuck, {L. Renee} and Sanders, {Melinda E.} and Dana Brantley-Sieders and Gorska, {Agnieszka E.} and Moses, {Harold L.} and Arteaga, {Carlos L.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1128/MCB.23.23.8691-8703.2003",
language = "English (US)",
volume = "23",
pages = "8691--8703",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

AU - Muraoka, Rebecca S.

AU - Koh, Yasuhiro

AU - Roebuck, L. Renee

AU - Sanders, Melinda E.

AU - Brantley-Sieders, Dana

AU - Gorska, Agnieszka E.

AU - Moses, Harold L.

AU - Arteaga, Carlos L.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - To determine if Neu is dominant over transforming growth factor β (TGF-β), we crossed mouse mammary tumor virus (MMTV)-Neu mice with MMTV-TGF-β1S223/225 mice expressing active TGF-β1 in the mammary gland. Bigenic (NT) and Neu-induced mammary tumors developed with a similar latency. The bigenic tumors and their metastases were less proliferative than those occurring in MMTV-Neu mice. However, NT tumors exhibited less apoptosis and were more locally invasive and of higher histological grade. NT mice exhibited more circulating tumor cells and lung metastases than Neu mice, while NT tumors contained higher levels of phosphorylated (active) Smad2, Akt, mitogen-activated protein kinase (MAPK), and p38, as well as vimentin content and Rac1 activity in situ than tumors expressing Neu alone. Ex vivo, NT cells exhibited higher levels of P-Akt and P-MAPK than Neu cells. These were inhibited by the TGF-β inhibitor-soluble TGF-β type II receptor (TβRII:Fc), suggesting they were activated by autocrine TGF-β. TGF-β stimulated migration of Neu cells into surrounding matrix, while the soluble TGF-β inhibitor abrogated motility and invasiveness of NT cells. These data suggest that (i) the antimitogenic and prometastatic effects of TGF-β can exist simultaneously and (ii) Neu does not abrogate TGF-β-mediated antiproliferative action but can synergize with TGF-β in accelerating metastatic tumor progression.

AB - To determine if Neu is dominant over transforming growth factor β (TGF-β), we crossed mouse mammary tumor virus (MMTV)-Neu mice with MMTV-TGF-β1S223/225 mice expressing active TGF-β1 in the mammary gland. Bigenic (NT) and Neu-induced mammary tumors developed with a similar latency. The bigenic tumors and their metastases were less proliferative than those occurring in MMTV-Neu mice. However, NT tumors exhibited less apoptosis and were more locally invasive and of higher histological grade. NT mice exhibited more circulating tumor cells and lung metastases than Neu mice, while NT tumors contained higher levels of phosphorylated (active) Smad2, Akt, mitogen-activated protein kinase (MAPK), and p38, as well as vimentin content and Rac1 activity in situ than tumors expressing Neu alone. Ex vivo, NT cells exhibited higher levels of P-Akt and P-MAPK than Neu cells. These were inhibited by the TGF-β inhibitor-soluble TGF-β type II receptor (TβRII:Fc), suggesting they were activated by autocrine TGF-β. TGF-β stimulated migration of Neu cells into surrounding matrix, while the soluble TGF-β inhibitor abrogated motility and invasiveness of NT cells. These data suggest that (i) the antimitogenic and prometastatic effects of TGF-β can exist simultaneously and (ii) Neu does not abrogate TGF-β-mediated antiproliferative action but can synergize with TGF-β in accelerating metastatic tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=0242552529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242552529&partnerID=8YFLogxK

U2 - 10.1128/MCB.23.23.8691-8703.2003

DO - 10.1128/MCB.23.23.8691-8703.2003

M3 - Article

VL - 23

SP - 8691

EP - 8703

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 23

ER -